Long-Acting Reversible Contraception

Jersey City, New Jersey, September 15, 2026 Organon has announced that the U.S. Food and Drug Administration (FDA) has...

JERSEY CITY, N.J., June 22, 2026 Organon has completed a global licensing agreement with Sebela Pharmaceuticals for MIUDELLA®, a...